Myron Holubiak
2017
In 2017, Myron Holubiak earned a total compensation of $694.1K as Chief Executive Officer at Citius Pharmaceuticals, a 60% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $225,000 |
|---|---|
| Option Awards | $19,114 |
| Salary | $450,000 |
| Total | $694,114 |
Holubiak received $450K in salary, accounting for 65% of the total pay in 2017.
Holubiak also received $225K in non-equity incentive plan and $19.1K in option awards.
Rankings
In 2017, Myron Holubiak's compensation ranked 10,648th out of 14,666 executives tracked by ExecPay. In other words, Holubiak earned more than 27.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,648 out of 14,666 | 27th |
Division Manufacturing | 4,153 out of 5,772 | 28th |
Major group Chemicals And Allied Products | 1,480 out of 2,075 | 29th |
Industry group Drugs | 1,210 out of 1,731 | 30th |
Industry Pharmaceutical Preparations | 941 out of 1,333 | 29th |
Source: SEC filing on December 13, 2017.
Holubiak's colleagues
We found two more compensation records of executives who worked with Myron Holubiak at Citius Pharmaceuticals in 2017.
News
Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
January 26, 2024
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018